Fibrosis on a chip for screening of anti-fibrosis drugs

Pulmonary fibrosis: Emerging diagnostic and therapeutic strategies

B Selvarajah, M Platé, RC Chambers - Molecular Aspects of Medicine, 2023 - Elsevier
Fibrosis is the concluding pathological outcome and major cause of morbidity and mortality
in a number of common chronic inflammatory, immune-mediated and metabolic diseases …
被引用次数：19 相关文章 所有 3 个版本
[PDF] ersjournals.comFree from Publisher

The evolution of in vitro models of lung fibrosis: promising prospects for drug discovery

E Kolanko, A Cargnoni, A Papait… - European …, 2024 - Eur Respiratory Soc
Lung fibrosis is a complex process, with unknown underlying mechanisms, involving various
triggers, diseases and stimuli. Different cell types (epithelial cells, endothelial cells …
被引用次数：8 相关文章 所有 10 个版本
[PDF] wiley.comFull View

Advances in organ‐on‐a‐chip for the treatment of cardiovascular diseases

J Liu, Y Wang - MedComm–Biomaterials and Applications, 2023 - Wiley Online Library
Cardiovascular disease (CVD) is currently a serious and growing public health problem. In
tackling this challenge, organ‐on‐chip (OoC) technology, combined with cell culture and …
被引用次数：3 相关文章 所有 2 个版本
[PDF] mcgill.ca

Effect of senescence on human mesenchymal stromal cells' anti-fibrotic function

IE Anaya Morales - 2024 - escholarship.mcgill.ca
Background: Age-associated fibrotic diseases significantly contribute globally to elevated
morbidity, mortality, and financial burdens. Fibrosis, a pathological response mirroring the …
相关文章

[图书][B] Effect of Senescence on Human Mesenchymal Stromal Cells' Anti-Fibrotic Function

IA Morales - 2023 - search.proquest.com
Background: Age-associated fibrotic diseases significantly contribute globally to elevated
morbidity, mortality, and financial burdens. Fibrosis, a pathological response mirroring the …
相关文章